HMS
CORT icon

Hanseatic Management Services’s Corcept Therapeutics CORT Stock Holding History

Hanseatic Management Services’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,001
Closed -$48K – 154
2021
Q1 		$48K Hold
2,001
– – 0.1% 75
2020
Q4 		$52K Buy
+2,001
New +$42.2K 0.11% 72

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hanseatic Management Services's CORT Position: Q2 2021 in Review

Hanseatic Management Services sold out of Corcept Therapeutics (CORT) in Q2 2021, closing a stake of 2,001 shares — an estimated $48K sold.

Hanseatic Management Services first reported a position in CORT in Q4 2020 and held it in 2 quarters. The position peaked at $52K in Q4 2020. 199 funds tracked by Wall St. Rank hold CORT as of Q2 2021.

  • Hanseatic Management Services reported no remaining Corcept Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Hanseatic Management Services sold 2,001 Corcept Therapeutics shares in Q2 2021, an estimated $48K.
  • Hanseatic Management Services first reported a position in Corcept Therapeutics in Q4 2020 and held it in 2 quarters.
  • Hanseatic Management Services's Corcept Therapeutics position peaked at $52K in Q4 2020.
  • 199 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2021.

Based on Hanseatic Management Services's 13F filing for Q2 2021, filed 30 Jul 2021.